PHARMACY COUNCIL OF INDIA IS THE SUPREME AUTHORITY: SC in a landmark judgment

The Supreme Court of India in its landmark judgment has ordered that the Pharmacy Council of India is the supreme authority to regulate pharmacy education and for approval of pharmacy courses and institutions in the country. The court further held that pharmacy education in the country should be governed by the Pharmacy Act, 1948, and dual regulation of pharmacy colleges needs to be ended forthwith and the AICTE Act governing the general technical education would be amended to delete ‘pharmacy’ from its mandate.

The apex court also held that both the Pharmacy Act and the PCI, the statutory body constituted under it, will prevail as far as the recognition of degrees and diplomas of pharmacy education is concerned. As per the Supreme Court order, the norms and regulations set by the PCI and other specified authorities under the Pharmacy Act should be followed by any institution imparting education for degrees and diplomas in pharmacy. After detailed examination of a bunch of petitions on the difficulties faced by pharmacy institutions due to dual regulations by PCI and AICTE, the court found that both the Pharmacy Act, 1948 and the AICTE Act, 1987, contain the provisions regarding pharmacy education leading to duplication of regulations and considerable confusion at the field level.

A three judges bench unanimously decided that this dual regulation should be ended forthwith and the AICTE Act governing the general technical education would be amended deleting ‘pharmacy’ from its mandate and the pharmacy education would thereafter be governed by the Pharmacy Act, 1948.

The Supreme Court’s decision is a welcome move in a right direction as there is definitely need for a stand-alone body like the PCI which comprehends the nuances of curriculum update in a fast transforming industrial environment in the pharmaceutical world.

Related Posts

Pharma companies in a flux over Trump’s 200% tariff move on generics

India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

New Delhi: A joint operation by the Delhi Police Crime Branch, the Central Drugs Standard Control Organisation (CDSCO) and the Gautam Buddha Nagar District Drug Department uncovered a suspected illegal…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

CDSCO declares 159 drug samples as NSQs in June

CDSCO declares 159 drug samples as NSQs in June